Pronova BioPharma appoints Morten Jurs as new CEO
Pronova BioPharma ASA announced that the board of directors has appointed Morten Jurs as new chief executive officer. Morten Jurs succeeds Per-Oluf Olsen.
Morten Jurs, aged 49, takes on his new role with effect from 1. July 2009. Mr Jurs has been chief financial officer of Pronova BioPharma since 2006. He has comprehensive experience as CFO from Kitron ASA, Santec Micro Group ASA, Telenor Nextra AS and Broadband Mobile ASA. Mr Jurs has also been CEO of Industrial Communication Group ASA. He holds an MBA from the University of Wyoming and has completed executive management courses at The Norwegian School of Economics and Business Administration.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.